Related Experiment Video
Updated: May 2, 2026

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
Striking follicular eruption to pegylated liposomal doxorubicin
Julia Dai1, Robert Micheletti, Misha Rosenbach
1Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Abstract:
The adverse effects of pegylated liposomal doxorubicin are primarily cutaneous. The majority of these cutaneous side effects manifest as palmar-plantar erythrodysesthesia, whereas few reports of other cutaneous reactions exist in the literature. The authors report a case of an exuberant follicular eruption in a patient treated with pegylated liposomal doxorubicin. This case also highlights the potential mechanism underlying this unusual histological and clinical reaction.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

